Rare Disease Legislative Advocates (RDLA) will bring together over 500 patient advocates in Washington, DC for a week of events dedicated to empowering patients, families, friends, and healthcare professionals to become legislative advocates. During the week of February 24-28, 2019, advocates will have an opportunity to meet with Members of Congress and learn best practices for successful advocacy.
Rare Disease Week on Capitol Hill 2019 kicks off on February 24th with a documentary screening and cocktail reception.
Patient advocates will attend the all-day Legislative Conference on February 25th to learn about federal legislation and policies that affect the rare disease community. Policy experts from Capitol Hill and non-profit organizations will share their expertise with advocates. In addition, advocacy professionals will teach attendees how to be effective advocates on the Hill and build strong relationships with their Members of Congress.
On February 26th, a Lobby Day breakfast will be held with keynote speakers. After breakfast, 500 rare disease advocates will go to Capitol Hill to meet with their Senators, Representatives, and Congressional staffers to discuss key legislation, policies and the Rare Disease Congressional Caucus.
The next day, the Rare Disease Congressional Caucus will host rare disease advocates and Congressional staffers for a lunch briefing on February 27th. Later in the evening, the Rare Artist Reception will feature the 2018 Rare Artist contest winning artwork and highlight the importance of art as therapy for rare disease patients.
We will close out the week at NIH in Bethesda, Maryland. On February 28th, the NIH will host Rare Disease Day at NIH. This event aims to raise awareness about rare diseases, the people they affect, and NIH research collaborations to advance new treatments. The EveryLife Foundation will be there to meet patients and provide information on their programs as well.
RDLA offers travel stipends to participants to offset the cost of attending Rare Disease Week on Capitol Hill. Stipend awardees in Maryland and Virginia will receive $400, and awardees in the rest of the continental United States will receive $800. Stipend awardees in Alaska, Hawaii, and Puerto Rico will receive $1000.
Two stipends will be awarded per state and limited to one per family. Stipends are prioritized to have a diverse representation of rare diseases and for those who have not attended Rare Disease Week or received a stipend in the past. The 2019 travel stipend application is open until December 14th, 2018 and can be found at rareadvocates.org/rdw. Applicants will hear by December 21st whether they will receive a travel stipend or have been placed on the waiting list.
Registration for Rare Disease Week on Capitol Hill begins on January 3, 2019. A hotel room block has been organized at the Washington Court Hotel in Washington, DC between February 24th and 28th for $219 per night. Attendees can contact the Washington Court Hotel directly and make a reservation with the “EveryLife Foundation” room block to reserve with this rate.
Information on Rare Disease Week on Capitol Hill 2019, the travel stipend application, and registration for the event can be found at rareadvocates.org/rdw.
We are excited for this powerful week of events and to continue to advocate with the rare disease community.
Heading in to election season, it’s important that the rare disease community’s voice is heard at the state and federal levels. To ensure our continued success, RDLA has put together a collection of resources to help advocates register to vote, know where their representatives stand on rare disease-related issues, and know about ballot initiatives that could affect the rare disease community.
- Vote411.org – This non-partisan site finds voter requirements for your state and helps you get registered.
- RDLA’s Legislative Scorecards – These scorecards list the voting record of your Members of Congress, offering a cumulative grade based on their support of recent federal legislation. If your representative doesn’t have a great track record on rare disease issues, In-District Lobby Days takes place from July 31st – September 4th, giving you a chance to speak with your legislator’s local office and encourage them to better support issues affecting rare disease patients.
- Rare Disease Congressional Caucus – A great way to tell if your representatives support the rare disease community is to see if they’re a member of the Rare Disease Congressional Caucus. The caucus convenes quarterly to inform Congressional offices about issues affecting rare disease patients.
- RARE on the Road – A partnership between the EveryLife Foundation and Global Genes, this tour of leadership events offers education on legislation currently being considered by Congress and an opportunity to meet other rare disease advocates in your local area. For those looking to move the needle on rare disease legislation or get an idea of how their representatives will vote on upcoming issues, RARE on the Road is a must-attend. Events will be hosted in Houston, Salt Lake City and Nashville this summer. For more information and to register, visit the RARE on the Road website.
- USA.gov – Hosts information on elections for state and local officials. Don’t know where your state representatives stand on rare disease issues? Check to see if your state has a rare disease caucus, or call your state representative’s office and ask for their stance on legislation affecting rare disease patients. RDLA provides tools to help advocates find the contact information for most of their elected officials.
- NORD State-by-State Report Cards – The National Organization for Rare Disorders (NORD) has comprised this useful guide offering state-by-state insights on medical food coverage, newborn screening, Medicaid elegibility and other issues that affect rare disease patients and their families.
- Ballot Inititatives – Based on your location, there may be local ballot initiatives that could affect the rare disease patient in your life. Ballotpedia provides neutral analysis of ballot initiatives at the state and local level so voters step in to the booth with the most information possible.
Notice a valuable voter resource that’s missing? Email Grant Kerber at firstname.lastname@example.org and we’ll add it to this page. Let’s make a difference in 2018!
Thank you to the 750+ rare disease patients, caregivers, researchers and other advocates who joined us during Rare Disease Week on Capitol Hill 2018, which took place February 25th through March 1st.
The week kicked off on Sunday evening at our 8th annual Rare Disease Documentary Screening and Cocktail Reception. The capacity crowd was treated to a screening of The Ataxian, which follows the journey of Freidreich’s Ataxia patients Kyle Bryant and Sean Baumstark as they bike across the United States. Following the screening, Kyle and Sean were on-hand to take questions from the crowd, with topics ranging from their lives with Freideich’s Ataxia to the filmmaking process.
On Monday, more than 450 advocates joined us in-person for the Legislative Conference, with more than 125 participating remotely through the event livestream. Experts from Capitol Hill and patient advocacy organizations discussed what to expect from Congress following changes to the Orphan Drug Tax Credit, how to build effective relationships with Members of Congress and their staff, and key pieces of legislation for 2018. Video and presentations will be available on the Legislative Conference resource page.
Tuesday morning, advocates began Lobby Day at breakfast with remarks by Joel White, Founder and President of Horizon Government Affairs. Mr. White was followed by Dr. William Gahl, Head of the Undiagnosed Diseases Program at the National Institutes of Health (NIH) and Debra Lewis, who serves as Acting Director of the Food and Drug Administration’s Office of Orphan Product Development. Advocates left the breakfast energized by the speakers and ready to educate Members of Congress and their staff about issues affecting the rare disease community.
And educate they did! In all, 371 advocates representing 49 states participated in a total of 294 Lobby Day meetings, discussing the Rare Disease Congressional Caucus, precision medicine legislation, incentives for rare disease drug development and other key legislative topics. Thanks to these advocacy efforts, the Rare Disease Congressional Caucus picked up 4 new members in the Senate and 9 in the House.
Wednesday’s events began with a Rare Disease Congressional Caucus briefing, titled “The Rare Disease Lifecycle: Diagnosis to Treatment.” Caucus Co-Chair Representative Leonard Lance (R-NJ) welcomed advocates and Congressional staff before our expert panel covered several topics affecting the rare disease community. Videos from the briefing are available here.
On Wednesday evening, we hosted the annual Rare Artist reception, which featured winning entries from the 2017 Rare Artist contest. We were honored to have seven awardees in attendance speak about the importance of art as therapy and the struggles they experience as rare disease patients. Also on display were photographs from Rick Guidotti’s Positive Exposure campaign, which put the beauty of rare disease patients on display for all to see.
We closed the week at the NIH, where EveryLife staff was on hand to meet attendees and provide information about our programs assisting the rare disease community.
After another successful year, we want to thank everyone who participated in Rare Disease Week on Capitol Hill in-person and remotely. Your support and appreciation means the world to us. We hope to see even more of our vibrant community in 2019!
We know that traveling to Washington, DC isn’t on option for all advocates. In order to better serve the rare disease community, we’ve provided a number of ways for advocates to participate in Rare Disease Week on Capitol Hill remotely. Below are five ways you can make your voice heard during next week’s events.
- Monday: Watch the livestream of the Legislative Conference on Monday, February 26th to learn about key legislation affecting the rare disease community. The draft agenda is available here, and you can register for the free livestream here.
- Tuesday: Call your Members of Congress on Lobby Day on Tuesday, February 27th. The one-page background papers for each of the key legislative issues discussed at the Legislative Conference will be available here prior to Rare Disease Week. You can review them and decide which you might want to ask your Members of Congress to support. You can find contact information for your elected officials here.
- Wednesday: On Wednesday, February 28th, join our Rare Disease Congressional Caucus briefing via livestream from 12:30 – 1:45 PM EST. Titled “The Rare Disease Lifecycle: Diagnosis to Treatment”, this briefing will provide insights on a number of steps in a rare disease patient’s journey.
- Thursday: Watch the livestream of Rare Disease Day at the National Institutes of Health (NIH) on Thursday, March 1st. The agenda and link to register are available on the NIH website. Speakers include leaders from NIH and the Food and Drug Administration (FDA), as well as representatives from a number of patient advocacy groups.
- Social media: Stay engaged with our acitivites by connecting with us on Facebook, Twitter and Instagram. On Twitter, we’re @RareAdvocates; On Instagram, we’re @Rare_Advocates. For posts related to Rare Disease Day or your own advocacy efforts, be sure to use our event hashtag, #RareDC2018, and to tag RDLA in your posts.
We hope that you will take part in these remote participation opportunities! If you have questions regarding any of these events, please email Grant Kerber at email@example.com.
Legislative Conference livestream presented by
Thank you to our 2018 sponsors.
As our Foundation continues to build its youth advocacy programming, we are pleased to offer a dedicated youth advocacy track for our 2018 Legislative Conference. This programming track echoes our belief that it is important for young adults to have their own voice when advocating for issues affecting the rare disease community, and aims to grow that voice to build confidence, develop political leadership skills and raise awareness.
The age range for our youth advocacy program is 13-25 yrs old. We strongly encourage event participants to be within this age range, but all are welcome.
Young adult events during RDWCH 2018
Monday, February 26th, 2018
Ronald Reagan Building and International Trade Center, Atrium Ballroom
1300 Pennsylvania Ave NW, Washington, DC 20004
Young Adults Track (2 sessions)
• Track C: Advocacy for Young Adults: Your Voice Matters
First, learn a little bit about how our government works. Then, meet and hear from some rare disease young adults who have been making a mark on Capitol Hill by telling their stories.
• Track C: Advocacy for Young Adults: Practice Meetings with Congressional Staff
Young adults can practice telling their stories to Congressional staffers. Attendees can get some tips and tricks for successful meetings on the Hill from those who know best.
Tuesday, February 27th, 2018
Young Adults Meet-Up (a debrief of your experiences on the Hill that day)
Songbyrd Music House and Record Café
2475 18 St NW, Washington, DC 20009
Wednesday, February 28th, 2018
Rare Artist Reception
Russell Senate Office Building Room 325
2 Constitution Ave NE, Washington, DC 20002
Award recipients from the 2017 Rare Artist contest will speak at the Rare Artist Reception, taking place on Wednesday, February 28th in Room 325 of the Russell Senate Office Building. Awardees from the Rare Artist contest’s Teen category will be present to speak about their work and the impact of rare disease on their lives. This is a chance to network with other young adults and view the artwork of the rare disease community. For more information on the reception and to register, click here.
For those who have already registered and are looking for other ways to prepare for Rare Disease Week on Capitol Hill, here are some tips:
- Tune into our webinar on Thursday, Feb. 15th. To register click here.
- Watch this video on “Tips on how to dress for Lobby Day”. You will hear directly from two of our speakers for the young adults track, Shira Strongin and Taylor Kane.
- If you need a letter from the EveryLife Foundation to excuse absence from school, please email our youth advocacy program director, Lindsey Cundiff at firstname.lastname@example.org.
- If you are interested in posting on social media throughout Rare Disease Week on Capitol Hill, keep these handles in mind.
Any other questions/concerns about the Youth Advocacy during Rare Disease Week on Capitol Hill, please email Lindsey Cundiff at email@example.com.
Social Media Info flyer design: Shira Strongin.
Earlier this month, Congress passed a Continuing Resolution (CR) extending Children’s Health Insurance Program (CHIP) funding for six years. The program provides affordable, comprehensive health insurance for children in families with too much income to qualify for Medicaid, but struggle to afford private insurance. Some states had to temporarily close enrollment or post notices about coverage loss after CHIP expired on September 30, 2017.
President Trump signed the CR into law earlier today. Energy and Commerce Committee Chairman Greg Walden (R-OR) and Health Subcommittee Chairman Michael C. Brugess (R-TX) stated that, “today is a win for the millions of kids and their families that rely on CHIP and its vital services. After a completely unnecessary and avoidable shutdown, families across the country can breathe a sigh of relief knowing they will continue having access to affordable, quality health insurance.”
Thank you to all who attended and supported our sixth annual RareVoice Awards. You helped us celebrate rare disease advocates who made an impact at state and federal levels. Enjoy photos from the event on our Facebook page and plan to join us February 25 through March 1, 2018 for Rare Disease Week on Capitol Hill.
Congratulations to our 2017 award recipients:
Senator Amy Klobuchar
Congressional Leadership RareVoice Award
Representative Leonard Lance
Congressional Leadership RareVoice Award
Senator Patty Murray
Congressional Leadership RareVoice Award
Remy Brim, Senate HELP Committee, Ranking Member Patty Murray
Congressional Staff RareVoice Award
Polly Webster, Office of Representative Diana DeGette
Congressional Staff RareVoice Award
Paul Fogelberg, Patient Advocate and Director, Pulmonary Fibrosis Advocates
Federal Patient Advocacy RareVoice Award
Emily Muller, Founder, Emily’s Fight
Federal Teen Advocacy RareVoice Award
Shira Strongin, Founder, Sick Chicks
Federal Teen Advocacy RareVoice Award
Becky Ruth, Member, Missouri State House of Representatives
State Legislator RareVoice Award
Darlene Shelton, Founder and President, Danny’s Dose
State Patient Advocacy RareVoice Award
Taylor Kane, Lead Advocate, Run for ALD
State Teen Advocacy RareVoice Award
Thank you to our sponsors for making this event possible!
On November 30th, the House Energy and Commerce Committee held a hearing to discuss, “Implementing the 21st Century Cures Act: An Update from FDA and NIH.” A year after 21st Century Cures Act was signed into law, Members of Congress asked Francis Collins, Director, National Institutes of Health (NIH) and Scott Gottlieb, Commissioner, Food and Drug Administration (FDA) to provide updates.
Representative Burgess (R-TX) opened the hearing by commending the bipartisan effort required to pass 21st Century Cures. He then went on to highlight key provisions like the Precision Medicine Initiative, Cancer Moonshot, the FDA Innovation Account, and modern clinical trial designs.
Scott Gottlieb emphasized that the FDA is currently examining how to leverage the agency’s accelerated approval pathway. Accelerated approval would include the authority to require confirmatory evidence to support continued marketing efforts and an expedited withdrawal mechanism if a treatment fails to show benefit. To fully leverage these opportunities, cancer drugs already approved for one indication could be approved for a supplemental application if evidence demonstrates. When Representative Matsui (D-CA) asked for updates on rare disease provisions in Cures, Dr. Gottlieb re-emphasized that the accelerated approval mechanism should be applied to rare disease trials when there is clear clinical benefit at an early stage. The FDA is already making robust use of provisions that allow, especially in the oncology setting, the agency to create supplemental indications without having to do additional clinical trials. This is especially relevant because, as Rep. Matsui pointed out, many rare disease patients take drugs off-label.
Click here to read the press release from the Energy and Commerce Committee.
The Senate Health, Education, Labor and Pensions (HELP) Committee will hold a hearing on the same topic on Thursday, December 7th.
After President Trump announced his intention to scrap health insurance marketplace subsidies via executive order earlier this month, Senators Patty Murray (D-WA) and Lamar Alexander (R-TN) introduced a bipartisan bill entitled, “the Health Care Stabilization Act of 2017” in an attempt to stabilize the marketplace. Insurer subsidies reimburse health insurance companies that reduce cost-sharing for lower-income Affordable Care Act (ACA) marketplace enrollees. Many critics of the executive order state that without insurer subsidies, millions of individuals would not be able to afford coverage. The bipartisan bill, which has 24 co-sponsors (12 Republican and 12 Democrat), would give states more funding flexibility to establish insurance stability funds and would provide expedited approval of Section 1332 state innovation waivers.
The Congressional Budget Office estimates that the bill could reduce the deficit by $3.8 million over the next 10 years. The CBO report also states that appropriating funds for cost-sharing reductions (CSRs), which the bill requires, would not affect direct spending or revenues relative to the current baseline projections.
In response to the Murray/Alexander legislation, Senate Finance Committee Chairman Orrin Hatch (R-UT) and House Ways and Means Committee Chairman Kevin Brady (R-TX) have announced that they will release legislation that extends the CSR program for two years, but repeals ACA mandates. The Ways and Means Committee has issued a press release.